Renoxome® by Koru Pharma
Renoxome® is an advanced skin rejuvenation solution from Koru Pharma, designed to deeply hydrate, repair, and revitalize the skin using exosome-based technology. Developed with next-generation biotechnology, Renoxome® harnesses the regenerative power of plant-derived exosomes, peptides, hyaluronic acid, and growth factors to enhance cellular communication and stimulate skin renewal at the molecular level.
Cellular Regeneration, Visible Rejuvenation
Renoxome Features.
Renoxome® is formulated with a high concentration of exosomes—nano-sized extracellular vesicles known for their role in intercellular signaling and tissue repair. These exosomes carry essential biomolecules that influence cell behavior, promoting collagen synthesis, skin elasticity, and dermal regeneration.
In addition to other exosomes, Renoxome® contains a synergistic blend of active ingredients including:
• Growth factors to accelerate skin healing and improve tone and texture
• Low-molecular-weight hyaluronic acid for deep hydration
• Amino acids and peptides to boost fibroblast activity and support skin structure
Renoxome® is commonly used in combination with microneedling, mesotherapy, or laser procedures, making it a versatile option for treating fine lines, acne scars, dullness, enlarged pores, and signs of aging.
About Koru Pharma
Koru Pharma is an international biopharmaceutical company headquartered in South Korea, specializing in regenerative medicine, aesthetic dermatology, and innovative cosmetic solutions. With a strong foundation in R&D and partnerships across Europe and Asia, Koru Pharma delivers cutting-edge products designed to support natural rejuvenation, skin regeneration, and non-invasive aesthetic enhancements. Their product lines are developed under stringent quality standards, ensuring both safety and efficacy for global medical professionals and patients.